The first models of the new Siemens ultrasound system Acuson S2000 Automated Breast Volume Scanner (ABVS) have taken up operation in European radiological and gynecological clinics and offices. Patients in Switzerland, France, Portugal, Norway and Germany can now be examined with the new system. Tha

One in eight women diagnosed with breast cancer is younger than 45 when diagnosed, yet their emotional and medical concerns are different than those of women over age 45, as is the impact of their diagnosis on family, friends, partners, colleagues and children. Fertility concerns and the possibility

Even with unemployment high and sales down, Safeway Inc. has donated more than $317,000 to fund breast cancer research at the Translational Genomics Research Institute (TGen). Donations raised in October during Breast Cancer Awareness Month increased the total contributions by Safeway to TGen over

A University of Melbourne study has revealed that certain breast cancer genetic variants increase mammographic density, confirming the link between mammographic breast density and breast cancer. Professor John Hopper of the University's School of Population Health says women vary greatly in their

Radiotherapy for breast cancer patients given as a lower overall dose in fewer higher doses (hypofractionated), does not seem to increase adverse symptoms or result in worse body image compared with the international standard treatment, according to the self-reported experience of patients. These re

Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body. The process cal

Biological-based therapies such as diet supplements and vitamins are the most popular complementary and alternative medicines for women recovering frombreast cancer, according to a Michigan State University researcher working to create a support intervention for women in treatment for the disease.

Breast cancer rates are declining, but some groups have seen a more significant decline than others, with race, ethnicity and economic background playing a part. According to a new national study, the only significant decline in breast cancer rates occurred among white, non-Hispanic women, 50 and o

An intense three-week course of radiation therapy is just as effective as the standard five-week regimen for women with early-stage breast cancer. Dr. Tim Whelan, a professor of oncology of the Michael G. DeGroote School of Medicine at McMaster University, led a team of researchers to find that wo

Agendia, a world leader in molecular cancer diagnostics, announced that it has received the Clinical Laboratory Permit from the New York State Department of Health. The New York State permit allows the company to receive commercial samples of MammaPrint, its FDA-cleared breast cancer recurrence test